Search Results - "Eckert, GP"

Refine Results
  1. 1

    Statin effects on cholesterol micro-domains in brain plasma membranes by Kirsch, Christopher, Eckert, Gunter P, Mueller, Walter E

    Published in Biochemical pharmacology (01-03-2003)
    “…Recent epidemiological studies revealed inhibitors of the hydroxymethylglutaryl-coenzyme A reductase, so-called statins, to be effective in lowering the…”
    Get full text
    Journal Article
  2. 2

    Omega-3 polyunsaturated fatty acids improve mitochondrial dysfunction in brain aging – Impact of Bcl-2 and NPD-1 like metabolites by Afshordel, Sarah, Hagl, Stephanie, Werner, Deborah, Röhner, Nelli, Kögel, Donat, Bazan, Nicolas G, Eckert, Gunter P

    “…Abstract The present study investigated the effects of orally administered long chain omega-3 polyunsaturated fatty acids (PUFA) on mitochondrial function and…”
    Get full text
    Journal Article
  3. 3

    Tocotrienols: constitutional effects in aging and disease by Schaffer, Sebastian, Müller, Walter E, Eckert, Gunter P

    Published in The Journal of nutrition (01-02-2005)
    “…Tocotrienols, a class of vitamin E analogs, modulate several mechanisms associated with the aging process and aging-related diseases. Most studies compare the…”
    Get more information
    Journal Article
  4. 4

    Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex by Johnson-Anuna, Leslie N, Eckert, Gunter P, Keller, Jan H, Igbavboa, Urule, Franke, Cornelia, Fechner, Thomas, Schubert-Zsilavecz, Manfred, Karas, Michael, Müller, Walter E, Wood, W Gibson

    “…Statins have been reported to lower the risk of developing Alzheimer's disease; however, the mechanism of this potentially important neuroprotective action is…”
    Get more information
    Journal Article
  5. 5

    Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease by Gibson Wood, W., Eckert, Gunter P., Igbavboa, Urule, Müller, Walter E.

    Published in BBA - Biomembranes (10-03-2003)
    “…Amyloid beta-protein (Aβ) is thought to be one of the primary factors causing neurodegeneration in Alzheimer's disease (AD). This protein is an amphipathic…”
    Get full text
    Book Review Journal Article
  6. 6

    Understanding local Mediterranean diets: A multidisciplinary pharmacological and ethnobotanical approach

    Published in Pharmacological research (01-10-2005)
    “…Epidemiological data indicate a beneficial effect of Mediterranean diets on human health, especially on the prevalence of cardiovascular disease. These…”
    Get full text
    Journal Article
  7. 7

    Statins: drugs for Alzheimer's disease? by Eckert, G P, Wood, W G, Müller, W E

    Published in Journal of Neural Transmission (01-08-2005)
    “…Evidences from cell culture experiments and animal studies suggest a strong link between cholesterol and Alzheimer's disease (AD). This relationship is…”
    Get full text
    Journal Article
  8. 8

    P06 Olesoxime improves specific features of the HD pathology by Clemens, LE, Wlodkowski, TT, Eckmann, J, Eckert, S, Michaud, M, Yu, L, Portal, E, Bordet, T, Pruss, R, Eckert, GP, Riess, O, Nguyen, HP

    “…BackgroundOlesoxime, a cholesterol-oxime, is a neuroprotective compound initially developed for the treatment of ALS (Bordet et al 2007). It interacts with…”
    Get full text
    Journal Article
  9. 9

    Lipid rafts of purified mouse brain synaptosomes prepared with or without detergent reveal different lipid and protein domains by Eckert, Gunter P, Igbavboa, Urule, Müller, Walter E, Wood, W.Gibson

    Published in Brain research (07-02-2003)
    “…Lipid rafts have been proposed to be important in a variety of functions including lipid transport, signal transduction and cell growth. There is increasing…”
    Get full text
    Journal Article
  10. 10

    Brain cholesterol, statins and Alzheimer's Disease by Kirsch, C, Eckert, G P, Koudinov, A R, Müller, W E

    Published in Pharmacopsychiatry (01-09-2003)
    “…Growing evidence suggests that cellular cholesterol homeostasis is causally involved in different steps leading to pathological events in the brain of…”
    Get more information
    Journal Article
  11. 11

    Membrane-disordering effects of beta-amyloid peptides by Müller, W E, Kirsch, C, Eckert, G P

    Published in Biochemical Society transactions (01-08-2001)
    “…beta-Amyloid (Abeta) protein is the major constituent of senile plaques and cerebrovascular deposits characteristic of Alzheimer's disease (AD). The causal…”
    Get more information
    Journal Article
  12. 12

    Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease by Eckert, G P, Cairns, N J, Maras, A, Gattaz, W F, Müller, W E

    Published in Dementia and geriatric cognitive disorders (01-07-2000)
    “…Cholesterol represents an important determinant of the physical state of biological membranes. In Alzheimer's disease (AD) brains, specific changes in the…”
    Get more information
    Journal Article
  13. 13

    Differential effects of lovastatin treatment on brain cholesterol levels in normal and ApoE-deficient mice by Eckert, Gunter P, Kirsch, Christopher, Mueller, Walter E

    Published in Neuroreport (17-04-2001)
    “…Growing evidence indicates that membrane cholesterol is involved in the development of Alzheimer's disease. Therefore, the availability of pharmacological…”
    Get full text
    Journal Article
  14. 14

    Cholesterol modulates amyloid beta-peptide's membrane interactions by Eckert, Gunter P, Kirsch, Christopher, Leutz, Steffen, Wood, W Gibson, Müller, Walter E

    Published in Pharmacopsychiatry (01-09-2003)
    “…The causal relationship between amyloid beta-peptide (Abeta) deposition and Alzheimer's disease (AD)-specific neuropathological lesions such as…”
    Get more information
    Journal Article
  15. 15

    Hyperforin modifies neuronal membrane properties in vivo by Eckert, Gunter P., Keller, Jan-Henning, Jourdan, Claudia, Karas, Michael, Volmer, Dietrich A., Schubert-Zsilavecz, Manfred, Müller, Walter E.

    Published in Neuroscience letters (02-09-2004)
    “…Hyperforin, the major active constituent of St. John Wort (SJW) extract, affects several neurotransmitter systems in the brain putatively by modulation of the…”
    Get full text
    Journal Article
  16. 16

    Determination of Hyperforin in Mouse Brain by High-Performance Liquid Chromatography/Tandem Mass Spectrometry by Keller, Jan-Henning, Karas, Michael, Müller, Walter E, Volmer, Dietrich A, Eckert, Gunter P, Tawab, Mona Abdel, Blume, Henning H, Dingermann, Theodor, Schubert-Zsilavecz, Manfred

    Published in Analytical chemistry (Washington) (15-11-2003)
    “…Hyperforin is one of the essential active ingredients of St. John's wort extract, which is used as an antidepressant for mild to moderately severe depressions…”
    Get full text
    Journal Article
  17. 17

    Is hypercholesterolemia a risk factor for Alzheimer's disease? by Wood, W Gibson, Igbavboa, Urule, Eckert, Gunter P, Johnson-Anuna, Leslie N, Müller, Walter E

    Published in Molecular neurobiology (01-01-2005)
    “…There is considerable attention being given to the association of Alzheimer's disease and cholesterol homeostasis. To that end, some have suggested that…”
    Get full text
    Journal Article
  18. 18

    Hypochlorous acid scavenging properties of local Mediterranean plant foods by Schaffer, S, Eckert, G.P, Muller, W.E, Llorach, R, Rivera, D, Grande, S, Galli, C, Visioli, F

    Published in Lipids (01-12-2004)
    “…Oxidative modification of low density lipoprotein (LDL) is involved in the pathogenesis of atherosclerosis and coronary heart disease, which are low in the…”
    Get full text
    Journal Article
  19. 19

    Murine synaptosomal lipid raft protein and lipid composition are altered by expression of human apoE 3 and 4 and by increasing age by Igbavboa, U., Eckert, G.P., Malo, T.M., Studniski, A.E., Johnson, L.N.A., Yamamoto, N., Kobayashi, M., Fujita, S.C., Appel, T.R., Müller, W.E., Wood, W.G., Yanagisawa, K.

    Published in Journal of the neurological sciences (15-03-2005)
    “…Apolipoprotein E (apoE) 4 and aging are risk factors for Alzheimer's disease (AD). Mice expressing human apoE4 and aged wild-type mice show a similarity in the…”
    Get full text
    Journal Article
  20. 20

    Piracetam: novelty in a unique mode of action by Müller, W E, Eckert, G P, Eckert, A

    Published in Pharmacopsychiatry (01-03-1999)
    “…Extensive research of the recent years has demonstrated that piracetam is effective in the treatment of cognitive decline in aging and dementia. It is usually…”
    Get more information
    Journal Article